Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Non Operating Income (2022 - 2024)

Spruce Biosciences (SPRB) has disclosed Non Operating Income for 3 consecutive years, with $808000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Non Operating Income fell 43.22% to $808000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $4.3 million, a 27.93% increase, with the full-year FY2021 number at $119000.0, down 40.5% from a year prior.
  • Non Operating Income was $808000.0 for Q3 2024 at Spruce Biosciences, down from $938000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.4 million in Q3 2023 to a low of $58000.0 in Q1 2022.
  • A 3-year average of $781250.0 and a median of $873000.0 in 2024 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: soared 1125.96% in 2023, then tumbled 43.22% in 2024.
  • Spruce Biosciences' Non Operating Income stood at $104000.0 in 2022, then skyrocketed by 1268.27% to $1.4 million in 2023, then crashed by 43.22% to $808000.0 in 2024.
  • Per Business Quant, the three most recent readings for SPRB's Non Operating Income are $808000.0 (Q3 2024), $938000.0 (Q2 2024), and $1.1 million (Q1 2024).